Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IVC | Common Shares | Tax liability | -$3.4K | -3.12K | -2.61% | $1.09* | 116K | May 15, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | IVC | Employee Stock Option (Right to Buy) | 71.9K | May 15, 2022 | Common Shares | 71.9K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | The surrender of these shares is for tax withholding purposes in conjunction with the vesting of restricted shares held by the reporting person. |
F2 | No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5. |
F3 | The reporting person holds previously reported options to buy 71,933 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan and the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. These options were granted between August 14, 2012 and March 16, 2017, at exercise prices between $12.15 to $14.49 per share, will expire between August 14, 2022 and March 16, 2027, and became exercisable between September 30, 2013 and February 19, 2020. |